FDA Label for Dermoscribe Seborrheic Dermatitis
View Indications, Usage & Precautions
Dermoscribe Seborrheic Dermatitis Product Label
The following document was submitted to the FDA by the labeler of this product Dermoscribe Pty Ltd. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
Sulfur 3%, Salicylic Acid 3%, Hydrocortisone 1%
Purpose
TREATMENT OF SEBORRHEIC DERMATITIS.
Use
Dermoscribe's Seborrheic Dermatitis Cream is a topical treatment for relief of the symptoms and signs of Seborrheic Dermatitis.
Warnings
FOR EXTERNAL USE ONLY. Avoid contact with mouth, eyes and anal skin.
Do not swallow. Seek medical advice before using if pregnant or breastfeeding. If irritation
develops, stop using and seek medical advice. May not be as effective after expiry date.
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN.
Directions
For use only by persons over 12 years old. Apply in a thin layer over the affected area once or twice daily as required.
Use only in accordance with the directions on the label and within the packaging. Refer to enclosed leaflet for detailed directions.
Inactive Ingredients
AQUEOUS CREAM
Other Safety Information
STORE AT ROOM TEMPERATURE
* Please review the disclaimer below.